Facebook Pixel

Comment Reply

EmpowHER Guest

Over 10 years ago, the Canadian government approved Botox(type A) for the treatment of ophthalmic disorders associated with muscle overactivity such as misalignment of the eyes and contractions of the eyelids. Since then, it has also received approval to relieve a variety of conditions involving hyperactive muscles.

April 29, 2009 - 7:10am


Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy